Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Xipere® (triamcinolone acetonide) – New drug approval
October 25, 2021 - Bausch + Lomb and Clearside Biomedical announced the FDA approval of Xipere (triamcinolone acetonide), for the treatment of macular edema associated with uveitis.
